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MaAfter 2 decades of development and use in interventional cardiology research, optical coherence tomography (OCT) has
now become a core intravascular imaging modality in clinical practice. Its unprecedented spatial resolution allows
visualization of the key components of the atherosclerotic plaque that appear to confer “vulnerability” to rupture—
namely the thickness of the ﬁbrous cap, size of the necrotic core, and the presence of macrophages. The utility of OCT
in the evaluation of plaque composition can provide insights into the pathophysiology of acute coronary syndrome and
the healing that occurs thereafter. A brief summary of the principles of OCT technology and a comparison with other
intravascular imaging modalities is presented. The review focuses on the current evidence for the use of OCT in identi-
fying vulnerable plaques in acute coronary syndrome and its limitations. (J Am Coll Cardiol Img 2015;8:198–209)
© 2015 by the American College of Cardiology Foundation.O ptical coherence tomography (OCT) is anintravascular imaging modality that usesthe reﬂection of near-infrared light to
generate an image. OCT was ﬁrst described more
than 2 decades ago when it was used to image the
peripapillary area of the human retina in vitro (1).
Eleven years later, OCT was used to image atheroscle-
rotic plaques in human coronary arteries (2). The im-
age resolution achievable with OCT (axial: 10 mm,
lateral: 20 to 40 mm) far surpasses that of intravas-
cular ultrasound (IVUS) (100 to 200 mm). Histological
studies have shown that certain adverse plaque phe-
notypes are associated with the onset of an acute cor-
onary syndrome (ACS) (3). With its excellent spatial
resolution, OCT is ideally placed to identify vulner-
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OCT TECHNOLOGY
To generate an image, a low-coherence, near-infrared
(wavelength of 1.3 mm) light source is directed at the
tissue (Figure 1). The light beam is split into 2 arms, a
sample arm and a reference arm, by an interferom-
eter. The reference arm is directed to a mirror, which
reﬂects the light directly back to the interferometer.
The light of the sample arm is absorbed, refracted, or
reﬂected from the sample tissue, scattering the light
at large angles from its surface and sub-surface. Re-
ﬂected light travels back to the interferometer andstle University, Newcastle upon Tyne Hospitals NHS
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AB BR E V I A T I O N S
AND ACRONYM S
ACS = acute coronary
syndrome
CKD = chronic kidney disease
DM = diabetes mellitus
IVUS = intravascular
ultrasound
NIRS = near-infrared
spectroscopy
OCT = optical coherence
tomography
SCAD = spontaneous coronary
artery dissection
STEMI = ST-segment elevation
myocardial infarction
TCFA = thin-cap ﬁbroatheroma
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 2 , 2 0 1 5 Sinclair et al.
F E B R U A R Y 2 0 1 5 : 1 9 8 – 2 0 9 OCT for Vulnerable Plaque
199interacts with the reference arm light. The interaction
between these 2 light waves determines the OCT im-
age, depending on whether there is constructive or
destructive interference between the waves (1).
Because red blood cells strongly scatter the light
waves and hence attenuate the image, OCT requires a
bloodless ﬁeld. The OCT catheter is connected to a
rotary junction, which uses a motor to rotate the
optical ﬁber in the catheter and couples light from
this rotating ﬁber to light from the reference arm. The
rotary junction is mounted to an automated pullback
device, thus scanning the artery in a helical fashion.
There are 2 types of OCT systems: time domain
(Figure 1A) and frequency domain (Figure 1B). The
ﬁrst-generation time domainOCT system required
sequential measurement of optical echoes from
different depths by moving the reference mirror (4).
This initially required the use of a balloon to occlude
coronary blood ﬂow, and the slow pullback speed of
1 to 5 mm/s led to image acquisition times of 3 to 45 s
(4). Subsequently, a blood-free imaging ﬁeld was
obtained by controlled intracoronary infusion of iso-
osmolar contrast, negating the need for an occlusive
balloon (5). This reduced the procedure time,
although the length of the analyzed segments of
artery were shorter (5). Second-generation frequency
domainOCT systems use a light source that is
rapidly swept in time across wavelengths from 1.25
to 1.35 mm, allowing simultaneous recording of
reﬂections from different depths without movement
of the reference mirror (6). Depth proﬁles are then
reconstructed by Fourier transformation. This speeds
up image acquisition 10-fold, with achievable pull-
back speeds of up to 40 mm/s and imaging runs of up
to 150 mm in length with a 3- to 5-s ﬂush of saline or
contrast, without the need for prolonged vessel oc-
clusion (6).
OCT IMAGE FEATURES. The normal coronary artery
is seen as a 3-layered structure on OCT (Figure 2A) (7).
The internal elastic lamina appears as a signal-rich
20-mm-thick band that lies inside the dark band of
the media and the further signal-rich band of the
external elastic lamina (7). An atherosclerotic lesion is
seen on OCT as a mass lesion within the arterial
wall, with focal intimal thickening or loss of the
normal vessel architecture (8). Fibrous plaque pro-
duces a relatively homogenous and highly backscat-
tering signal (8) (Figure 2B). Calciﬁed plaques appear
as a signal-poor area with sharply delineated
borders (Figure 2C). However, this only applies to
larger regions of calciﬁcation; smaller areas and
microcalciﬁcations have yet to be validated against
histology (8). Necrotic core (and the broader histo-
pathological category of a lipid pool) is seen as asignal-poor region with poorly deﬁned bor-
ders and fast OCT signal drop-off (Figure 2D)
(8). Because light does not penetrate through
these areas, OCT cannot be used to measure
the depth or volume of lipid pools. Macro-
phage accumulations can sometimes be seen
at the border of the ﬁbrous cap and necrotic
core, and can appear as punctate signal-rich
spots that exceed the background noise of
the image (8). Cholesterol crystals are linear
regions of high intensity, often associated
with a lipid pool (Figure 3C) (8). OCT can dif-
ferentiate between white and red thrombus
(Figure 4) due to the high proportion of red
blood cells in red thrombi, which causes
greater attenuation of the OCT signal and a
lower half-width (the distance from peak
signal intensity to its half-intensity). Kume et al. (9)
showed that a cutoff of 250 mm in the half-width
could accurately discriminate between white and
red thrombus with a sensitivity of 90% and a speci-
ﬁcity of 88%.
HISTOLOGICAL VALIDATION OF OCT. OCT was ﬁrst
validated for plaque characterization in vitro in 2002
(10). Agreement between the histopathological and
OCT ﬁndings were high (k ¼ 0.83 to 0.84), and inter-
observer and intraobserver reliability were good (k ¼
0.88 and k ¼ 0.91, respectively) (10). However, there
were a number of false-negative diagnoses of lipid
pools, which could be attributed to the limited
penetration of OCT, leading to deep lipid pools being
misinterpreted as ﬁbrous plaques. Intimal thickness
measured by OCT also correlated well with histology
(r ¼ 0.98, p < 0.001) (11). However, OCT images are
prone to artifacts; 30.9% of images contained artifacts
in 1 study, although this improved with operator
experience (12). Seam-line artifacts cause apparent
breaks in the lumen contour on the cross-sectional
image (6.0% of images); decentration artifacts are
caused by eccentric positioning of the imaging cath-
eter within the artery and lead to image attenuation
in remote structures (30.9%); caliber artifacts are
caused by an arterial diameter greater than the
penetration limit of the OCT and are a particular
problem in vein grafts and in the left main stem (13)
(15.0%); and ﬂow artifacts are caused by failure to
clear blood from either the vessel or imaging catheter
by ﬂushing (19.6%) (12).
OCT AND VULNERABLE PLAQUES
DEFINITION OF THIN-CAP FIBROATHEROMA. His-
topathological studies have identiﬁed anatomical
characteristics of “vulnerable” plaques that are
FIGURE 1 Diagrammatic Representation of OCT
The 2 types of optical coherence tomography (OCT) systems, (A) time domain and (B) frequency domain, are displayed.
Sinclair et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 2 , 2 0 1 5
OCT for Vulnerable Plaque F E B R U A R Y 2 0 1 5 : 1 9 8 – 2 0 9
200implicated in the pathophysiology of ACS. These
plaques, which are prone to rupture, have ﬁbrous
caps that are thinned and rich in macrophages over-
lying a lipid pool (14). A previous study examined the
hearts of 113 men that died suddenly, of which 41 had
acute coronary artery thrombosis secondary to
rupture of an atherosclerotic plaque, and 95% of these
subjects had plaques with ﬁbrous caps <65-mm thick
(mean thickness, 23  19 mm) with an inﬁltrate of
macrophages (15), subsequently termed thin-cap
ﬁbroatheroma (TCFA) (16). Due to the high image
resolution with OCT, it is well placed to identify these
high-risk plaques in vivo (Figure 5). However, there isstill debate over the exact deﬁnition of a TCFA on
OCT (OCT-TCFA) because histological specimens of
TCFA differ from OCT images (likely due to shrinkage
of pathological specimens). Using a cutoff of 70 mm
(as the axial resolution of OCT is >10 mm), only 67% of
ruptured plaques in 1 study of 72 patients with ACS
were deﬁned as having a thin ﬁbrous cap (17).
Therefore, it is possible that the ﬁbrous cap of a TCFA
is thicker in vivo than on histology. There is a higher
proportion of lipid-rich plaque on OCT in patients
with ACS compared with stable angina (18), and some
studies have used an additional parameter to deﬁne a
TCFA: that the arc of the lipid pool should subtend an
FIGURE 2 OCT Image Examples of Plaque Composition
(A) Composition of the normal coronary artery, with white arrows depicting the internal elastic lamina, media and external elastic lamina.
(B) Concentric ﬁbrous plaque. (C) Calciﬁed plaque. (D) Necrotic core. *Guidewire artifact. Abbreviation as in Figure 1.
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201angle >90 (8). However, there is no consensus on the
exact cutoff value for the ﬁbrous cap or arc of lipid
pool for the identiﬁcation of an OCT-TCFA, only that
the deﬁnition of an OCT-TCFA should reﬂect the
histological deﬁnition of a TCFA (8).
TCFA IN ACS. TCFAs are more common in patients
with an acute or unstable clinical presentation than
stable angina pectoris patients. A comparison of 26
acute ST-segment elevation myocardial infarction
(STEMI) patients with 16 stable angina patients
showed that STEMI patients had a higher proportion
of OCT-TCFA in the culprit lesion (85% vs. 13%,
p < 0.001) and a thinner ﬁbrous cap (57  12 mm vs.
180  65 mm, p < 0.001) (19). Patients with STEMI also
had a higher prevalence of OCT-TCFA compared with
patients with nonST-segment elevation ACS (78%
vs. 49%, p ¼ 0.008) (20). Similar results have been
shown in patients with unstable angina compared to
patients with stable angina (incidence of OCT-TCFA
81% vs. 47%, p ¼ 0.002; ﬁbrous cap thickness of 56
 20 mm vs. 75  30 mm, p < 0.001) (21). Patients with
ACS also have a higher proportion of OCT-TCFA andthinner ﬁbrous caps than found in non-ACS patients
(19,22). In patients with ACS, OCT-TCFAs are more
commonly found in the proximal segments of the
culprit vessel (23,24). OCT has been used to conﬁrm
ﬁndings from histological studies that plaque rupture
of TCFA occurs more often away from the site of
minimum lumen area in patients with STEMI and
non-STEMI (mean distance of site of rupture from
minimum lumen area ¼ 2.34  2.31 mm) (25).
Atherosclerotic lesions are dynamic, and there is
evidence from IVUS studies that TCFAs can trans-
form into other plaque types and vice versa. A study
of nonculprit lesions in patients with STEMI showed
that 9 of 41 TCFAs identiﬁed by virtual histology–
IVUS had healed into more stable lesions at 13-month
follow-up, but 21 of 57 other lesions had transformed
into TCFAs (26). However, in a study evaluating
bifurcation lesions with both OCT and virtual
histology-IVUS, 83% of high-risk plaques remained
unchanged at 6months (27). Further serial OCT studies
are required to investigate the natural history of these
vulnerable plaques in patients with ACS.
FIGURE 3 Cholesterol Crystals
Images from an 80-year-old female patient with hypertension and hypercholesterolemia who presented with a nonST-segment elevation
myocardial infarction. (A) Angiogram showing a tight stenosis with thrombus in the mid-left anterior descending artery (white arrow). (B) OCT
image of red (red arrow) and white (white arrow) thrombus in the culprit lesion. (C) OCT image of cholesterol crystals (white arrows) and
macrophage accumulation (red arrow). *Guidewire artifact. OCT ¼ optical coherence tomography.
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202EFFECTS OF THERAPY ON TCFA. Methods to stabilize
these vulnerable TCFAs have been assessed using
serial OCT studies. Patients who underwent statin
therapy had an increased cap thickness of OCT-TCFA
compared with patients who were not being admin-
istered statins (an increase of 192  41 mm vs. 25 
8 mm, p < 0.001) at 9 months post-ACS study (28). In a
prospective study of 42 patients with stable angina,
statin therapy resulted in an increase in ﬁbrous cap
thickness when compared with dietary modiﬁcation
alone (þ52  32 mm vs. 2  22 mm, p < 0.001) (29).FIGURE 4 Red and White Thrombus
(A) Red thrombus (red arrow) with high attenuation, associated with a ca
low-attenuation white thrombus (white arrow). *Guidewire artifact.Another study enrolled 30 patients (56.6% with ACS)
with untreated dyslipidemia and OCT-TCFA on
baseline imaging, and randomized them to either
statin therapy alone or statin þ eicosapentaenoic acid
(30). Despite similar levels of low-density lipoprotein
at follow-up examination, those who received eico-
sapentaenoic acid had a greater increase in ﬁbrous
cap thickness (54.8  27.9 mm vs. 23.5  11.6 mm, p <
0.0001) (30). However, it remains to be seen whether
stabilizing these plaques actually improves clinical
outcomes.lciﬁed plaque (yellow arrow). (B) Stent thrombosis with homogenous,
FIGURE 5 Thin-Cap Fibroatheroma
Images from an 83-year-old male ex-smoker, who presented with a non–ST-segment elevation myocardial infarction. He underwent
percutaneous coronary intervention to a culprit lesion in the left anterior descending artery, but OCT imaging of the right coronary artery
revealed a nonobstructive thin-cap ﬁbroatheroma in the nonculprit artery. (A) Angiogram with a nonobstructive mild atheroma in the right
coronary artery (red bar). (B) OCT image of the thin-cap ﬁbroatheroma (white arrow). (C) VH-IVUS image of the thin-cap ﬁbroatheroma (white
arrow). *Guidewire artifact. OCT ¼ optical coherence tomography; VH-IVUS ¼ virtual histology–intravascular ultrasound.
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203RUPTURED PLAQUES. Ruptured plaques with
thrombus have thinner ﬁbrous caps than those
without thrombus (57  17 mm vs. 96  48 mm, p ¼
0.0076) (31). Intracoronary thrombus is well visualized
by OCT and is almost universally found in STEMI (19).
However, care must be taken with interpretation of
these results, as overlying thrombus may interfere
with OCT characterization of the lesion, and perform-
ing thrombus aspiration before OCT imaging may alter
the underlying plaque anatomy. Patients with ACS
caused by ruptured culprit plaques are more likely to
have nonculprit plaques with a higher lipid index
(mean lipid arc multiplied by lipid length measured in
the longitudinal view: 1,196.9 700.5 vs. 747.7 377.3,
p ¼ 0.001), higher incidence of OCT-TCFA (52.9% vs.
19.0%, p ¼ 0.029), and thinner ﬁbrous caps (107.0 
56.5 mm vs. 137.3  69.8 mm, p ¼ 0.035) on OCT than
those with nonruptured culprit plaques (32). Patients
with ruptured culprit plaques were also more likely
to have secondary, nonculprit plaques ruptures
(35.3% vs. 4.8%, p ¼ 0.016) (32). This suggests that
these patients have increased pan-coronary vulnera-
bility and may be at higher risk of future adverse
events. In addition, plaque ruptures in patients with
ACS differ from those found in patients with asymp-
tomatic coronary artery disease with a greater lipid
arc (171  71 vs. 133  71, p ¼ 0.037), higher incidence
of thrombus (78% vs. 9%, p < 0.001), and a smaller
minimum lumen area of the culprit lesion (1.79 
0.92 mm vs. 2.75  0.99 mm, p < 0.001), suggesting
that the morphology of the plaque rupture may inﬂu-
ence whether it heals asymptomatically or causes an
adverse cardiovascular event (33).PLAQUE EROSION. In contrast to plaque rupture,
plaque erosion is characterized by luminal thrombus
and absence of the endothelium, without evidence
of ﬁbrous cap disruption (3). In 1 histological study,
erosions were responsible for more than 40% of
thrombotic sudden cardiac deaths and were more
prevalent in women (14). Although OCT does not have
the resolution necessary to identify the absence of the
endothelium, OCT-identiﬁed plaque erosion has been
deﬁned as the presence of thrombus and an irregular
luminal surface in the absence of cap rupture (8). In a
cohort of patients with STEMI (n ¼ 30), plaque ero-
sions were more often found by OCT than by IVUS or
angioscopy (23% vs. 3% vs. 0%, p ¼ 0.003) (34). In a
previous study, OCT was performed in 126 patients
with ACS and showed plaque rupture in 43.7%,
erosions in 31%, and calciﬁed nodules in 7.9% (35).
Plaque erosions were more commonly observed in
younger patients (53.8  13.1 years vs. 60.6  11.5
years, p ¼ 0.005), and were more commonly associ-
ated with non-STEMI than STEMI (61.5% of patients
with non-STEMI had a plaque erosion vs. 29.1% of
STEMI patients, p ¼ 0.008). Patients with plaque
erosion had a less severe diameter culprit stenosis
than those with plaque rupture (55.4  14.7% vs.
68.8  12.9%, p < 0.001) (35). Plaque erosion on
OCT was associated with a higher level of serum
myeloperoxidase, a hemoprotein released on neu-
trophil activation, than plaque rupture (2,500 ng/ml
vs. 707 ng/ml, p ¼ 0.001) (36).
Prati et al. (37) performed OCT after thrombus
aspiration in patients with STEMI and followed up 31
patients with plaque erosion for 1 year. Twelve
FIGURE 6 Microchannel
OCT image showing a microchannel (yellow arrow) associated
with a nonobstructive lesion with a large necrotic core (white
arrow). *Guidewire artifact. †Seam line artifact. OCT ¼ optical
coherence tomography.
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204patients were managed with thrombus aspiration
only, and 19 had thrombus aspiration plus angio-
plasty. There were no signiﬁcant differences in out-
comes (death, myocardial infarction, and target
vessel revascularization) between the groups (37).
Although this study raised the possibility of using
OCT to inﬂuence the management of patients with
ACS, this study is limited in that it consisted of too
small a sample size to draw deﬁnitive conclu-
sions, and treatment was not randomized (patients
managed conservatively were younger and had fewer
cardiac risk factors).
PLAQUES WITH CALCIFIED NODULES. Plaques with
superﬁcial calciﬁed nodules are also considered prone
to rupture (16,38). The pattern of plaque calciﬁcation
on OCT was evaluated in 187 patients with acute
myocardial infarction and unstable and stable angina.
Patients with acute myocardial infarction and unsta-
ble angina had less overall calcium (measured by arc,
area, and length, p < 0.001 for all measurements) than
those with stable angina, but were more likely to have
spotty calcium deposits closer to the surface of the
plaque (39). The incidence of calciﬁed nodules in
ACS in 1 study was 8%, but was more common with
increasing age (35). However, the accuracy of OCT in
identifying smaller areas of calciﬁcation has also yet
to be validated against histology (8).
MACROPHAGE INFILTRATION AND MICROCHANNEL
FORMATION. The resolution of OCT may allow
identiﬁcation of macrophages within an atheroscle-
rotic plaque. In ACS patients, a higher prevalence of
macrophage inﬁltration in nonculprit plaques was
found compared with non-ACS patients (82.4% vs.
37.9%, p ¼ 0.001) (22). A study of diabetic patients
also found those with poorly controlled diabetes
(glycated hemoglobin $ 8%) had greater macrophage
inﬁltration than nondiabetic patients or well-
controlled diabetic patients (37.9% vs. 11.0%, p ¼
0.037) (40). Plaques that exhibited an increase in
luminal stenosis over time were more likely to have
higher numbers of macrophages (odds ratio [OR]: 9.6,
p ¼ 0.001), TCFA (OR: 20, p < 0.001), intimal lacera-
tion (OR: 10.2, p < 0.001), and/or microchannels
(OR: 20, p < 0.001) (41). Plaque neovascularization
and microchannel formation (Figure 6) are known to
be markers of plaque vulnerability and rupture, as
well as intraplaque hemorrhage, which can contribute
to plaque progression (42). Patients with micro-
channels in the culprit lesion were more likely to have
presented with unstable than stable angina (83% vs.
17%), have a thinner ﬁbrous cap (60 mm vs. 100 mm,
p ¼ 0.001), and have a trend towards a higher inci-
dence of plaque rupture (50% vs. 28%, p ¼ 0.11) (43).COMPARISON WITH OTHER
INTRAVASCULAR MODALITIES
Table 1 shows the properties of the different available
clinical intravascular imaging modalities. A combi-
nation of these imaging techniques may provide a
more detailed and complete visualization of plaque
pathology.
INTRAVASCULAR ULTRASOUND. Because of its
greater resolution and obligatory ﬂushing and blood
clearing, OCT is more accurate than either IVUS or
quantitative coronary angiography in determining
luminal dimensions (44). Frequency domainOCT
provides more accurate measurement of the minimal
lumen area than either IVUS or quantitative coronary
angiography in both phantom models and in vivo (r2 ¼
0.95, p < 0.001, mean difference 0.41 mm2) with good
intra- and interobserver reproducibility (r2 ¼ 0.999,
p < 0.001, mean difference 0.01 mm2) (44). Virtual
histologyIVUS cannot visualize the ﬁbrous cap but
can quantify the necrotic core of the plaque (Figure 5C)
(45). Virtual histologyIVUS was shown to have
acceptable sensitivity (89%) and speciﬁcity (86%) in
identifying TCFA compared with OCT (46). A hybrid
IVUSOCT catheter has been developed and simulta-
neously provides both the resolution and penetration
required to identify and quantify TCFA (47,48).
TABLE 1 Comparison of the Physical Properties of Different
Modalities of Intravascular Imaging
OCT IVUS
Near-Infrared
Spectroscopy
Energy source Infrared Ultrasound Near-infrared
Wavelength (mm) 1.3 35–80 0.8–2.5
Penetration (mm) 1–2.5 10 1–2
Resolution (mm) 20–40 100–200 NA
Pullback speed (mm/s) 10–40 0.5–1 0.5
IVUS ¼ intravascular ultrasound; NA ¼ not available; OCT ¼ optical coherence
tomography.
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205FRACTIONAL FLOW RESERVE. Although OCT is
a structural imaging technique, there have been
attempts to correlate it with functional measures of
stenosis severity, such as fractional ﬂow reserve.
Table 2 summarizes the studies that have correlated
minimum lumen area (measured by OCT) and frac-
tional ﬂow reserve. The ILUMIEN 1 study is currently
recruiting to ascertain whether a combined OCT and
fractional ﬂow reserve device aids periprocedural
decision making that may have an impact on patient
outcomes (49).
NEAR-INFRARED SPECTROSCOPY. Near-infrared spec-
troscopy (NIRS) can only quantify the lipid content of
the plaque, but the signal can pass through calcium
and accurately quantify lipid behind this (50). NIRS
provides only compositional information regarding
the plaque, but does not require a bloodless ﬁeld (51)
and can help discriminate between calcium and
necrotic core, which can often be misinterpreted on
OCT (52). A comparison using a hybrid NIRS-IVUS
catheter with OCT showed that plaque burden, posi-
tive remodeling, and lipid index measured by the
hybrid catheter were associated with OCT-TCFA (53).
A hybrid NIRS-OCT catheter is in development, and a
proof-of-concept demonstration has been published,TABLE 2 Summary of Studies Comparing FFR and OCT
First Author, Year (Ref. #) Lesions Assessed Type of OCT FFR
Zafar et al., 2014 (88) N ¼ 41
>30% stenosis
FD-OCT <0.8
Reith et al., 2013 (89) N ¼ 62
40%–70% stenosis
Diabetic patients
FD-OCT <0.8
Pyxaras et al., 2013 (90) N ¼ 55
30%–50% stenosis
FD-OCT <0.8
Pawlowski et al., 2013 (91) N ¼ 48
40%–70% stenosis
Non-occlusive
TD-OCT
<0.8
Gonzalo et al., 2012 (92) N ¼ 61
40%–70% stenosis
FD-OCT <0.8
Shiono et al., 2012 (93) N ¼ 62
>30% stenosis
Occlusive
TD-OCT
<0.75
FD-OCT ¼ frequency domain optical coherence tomography; FFR ¼ fractional ﬂow reser
tomography.successfully imaging a 3-cm section of 1 human
coronary artery ex vivo to provide simultaneous
structural and compositional information (54).
3-DIMENSIONAL RECONSTRUCTION. As the tech-
nology of OCT becomes more reﬁned and image
acquisition faster, it has become possible to perform
3-dimensional reconstructions of the coronary anat-
omy by fusing x-ray and OCT data (55,56). This allows
assessment of local hemodynamic ﬂow patterns and
hence the effects of endothelial shear stress on the risk
of plaque progression and rupture (57). Three-
dimensional IVUS studies have shown that localized
elevation of shear stress is correlated with the plaque
rupture site in patients with ACS (k ¼ 0.79) (58). How-
ever, this has not yet been studied using OCT.
NONINVASIVE IMAGING. Noninvasive techniques
such as positron emission tomographycomputed
tomography have been used to identify vulnerable
plaques and correlate with high-risk features on
virtual histologyIVUS. In 40 patients with stable
angina, high 18F-sodium ﬂuoride uptake (postulated
to be a marker of plaque activity) correlated with
virtual histologyIVUS features such as micro-
calciﬁcation (73% vs. 21%, p ¼ 0.002) and higher mean
necrotic core (24.6 vs. 18.0, p ¼ 0.001), which may be
markers of plaque vulnerability, and there was a
nonsigniﬁcant trend towards a higher prevalence of
TCFA in 18F-sodium ﬂuoride positive plaques (47% vs.
16%, p ¼ 0.068) (59). However, these noninvasive
techniques lack the spatial resolution of OCT, and it
has not yet been investigated whether OCT can
complement the data obtained from positron emis-
sion tomographycomputed tomography.
OTHER APPLICATIONS OF OCT
NEOATHEROSCLEROSIS. The advent of OCT has
allowed in vivo imaging of conditions that wereMLA Cutoff Positive Predictive Value Negative Predictive Value Sensitivity Speciﬁcity
0 <1.62 mm2 89% 91% 97% 70%
0 <1.59 mm2 80.6% 74.2% 75.8% 79.3%
0 <2.88 mm2 Not reported Not reported 73% 71%
0 <2.05 mm2 Not reported Not reported 75% 90%
0 <1.95 mm2 66% 80% 83% 63%
<1.91 mm2 80.6% 92.3% 93.5% 77.4%
ve; MLA ¼ minimum lumen area; OCT ¼ optical coherence tomography; TD-OCT ¼ time domain optical coherence
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206previously poorly understood. In-stent restenosis was
previously thought to be a condition mainly of bare-
metal stents that regressed with time (60). However,
more recently, evidence has emerged of late in-stent
restenosis of both bare-metal and drug-eluting
stents presenting as ACS (61,62). An early OCT study
of in-stent restenosis in bare-metal stents showed
that the initial neointimal proliferation after stent
implantation could transform into lipid-rich plaque
with evidence of intimal disruption and thrombus
(63). TCFAs were identiﬁed in more than one-half of
drug-eluting stent restenosis cases, and features of
neoatherosclerosis were more common in those pre-
senting with unstable angina than those patients
with stable symptoms (64). In 1 serial OCT study
of drug-eluting stents, 30.3% of those with homo-
genous neointimal proliferation had evidence of
transformation to neoatherosclerosis (65). On multi-
variate analysis, stent age >4 years, chronic kidney
disease (CKD), and smoking were predictors for neo-
atherosclerosis on OCT (66). Neoatherosclerosis is
also observed more often in patients with diabetes
mellitus (DM), and more often in poorly controlled
DM (67). Patients with neoatherosclerosis have a
higher rate of target vessel revascularization and
stent thrombosis (68).
SPONTANEOUS CORONARY ARTERY DISSECTION. OCT
can also provide a valuable insight into less common
causes of ACS, such as spontaneous coronary artery
dissection (SCAD) and coronary artery spasm. SCAD is
a non-traumatic, spontaneous separation of the
vessel wall by intramural hemorrhage, with creation
of a false lumen, and may be easily missed on angi-
ography (69). OCT is advocated as the gold-standard
intravascular imaging modality in detecting SCAD
because it can visualize the false lumen, intimal
rupture, and intramural thrombus more accurately
than IVUS (70). In 17 patients suspected of having
SCAD, OCT conﬁrmed its presence in 11 (64.7%),
showing a double lumen or intramural hemorrhage in
all patients, whereas angiography only showed an
intimal ﬂap in 3 patients (71). SCAD was observed in
4% of cases in a recent ACS cohort, and was more
common in women than men (72). A diagnostic al-
gorithm has been proposed if there is a high index of
suspicion of SCAD (for example, in a young woman
without traditional risk factors presenting with ACS),
advocating the use of OCT or IVUS to conﬁrm the
diagnosis (69).
CORONARY ARTERY SPASM. Coronary artery spasm
(mediated by endothelial dysfunction and atheroma
that is not visible on conventional angiography)
can also result in ACS, and 1 OCT study of 20 patientswith coronary vasospasm (conﬁrmed by provocation
testing) showed intraluminal thrombus and intimal
erosion in a signiﬁcant proportion of cases (33.3% and
10%, respectively) (73). One study showed that
patients with coronary artery spasm after an acetyl-
choline provocation test were more likely to have
homogenous intimal thickening than those without
coronary spasm (74). However, another OCT study
suggested that contraction of the media facilitated
intimal gathering without intimal thickening during
coronary artery spasm (75). Further research is
needed into the pathophysiology of coronary artery
spasm, and OCT is ideally placed to identify the role
of plaque erosion and changes in the intima during
spasm.
OCT PLAQUE CHARACTERIZATION IN
VULNERABLE PATIENTS
DIABETES MELLITUS. Patients with DM are at
increased risk of adverse events after ACS (hazard
ratio for cardiac death at 1 year was 3.33, 95% conﬁ-
dence interval: 1.3 to 8.6, p ¼ 0.008) (76). However,
studies have shown a similar prevalence of TCFA in
DM and non-DM patients undergoing angioplasty for
any reason (29% in patients with DM vs. 36% in those
without, p ¼ 0.76) (77), and in patients with unstable
angina (42.9% vs. 52.3%, p ¼ 0.34) (78). In an OCT
substudy of 72 patients with ACS, patients with DM
had smaller lipid pools, greater extent of calciﬁcation,
and a greater frequency of superﬁcial calciﬁed nod-
ules, with no difference in the prevalence of TCFA
between groups (79). Features of plaque vulnerability
are, however, associated with glycemic control in
diabetic patients, with patients with a glycated
hemoglobin level $8% found to have a larger lipid
pool, thinner ﬁbrous cap, and greater prevalence of
TCFA in nonculprit lesions (40).
RENAL DYSFUNCTION. Ischemic heart disease is the
leading cause of death in patients with CKD (80). In a
study of 287 patients enrolled in the Massachusetts
General Hospital OCT Registry (26.5% with ACS),
patients with CKD had a larger lipid index compared
with those without (average lipid arc multiplied by
lipid length: 1,716.1  1,116.2 mm vs. 1,248.4  782.8
mm, p ¼ 0.003) (81). Plaque disruption was more
frequently found in the CKD than the non-CKD group
(13.5% vs. 5.5%, p ¼ 0.049), but there were no differ-
ences in ﬁbrous cap thickness between the groups (81).
CARDIAC ALLOGRAFT VASCULOPATHY. OCT has
been used in patients with cardiac transplants to
identify the characteristics of cardiac allograft vas-
culopathy. Patients with high-grade rejection aremore
likely than thosewithmild/no rejection to have thicker
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207intima (0.34 mm vs. 0.15 mm in the proximal coronary
artery segment, p ¼ 0.005), higher prevalence of
macrophages (44% vs. 15%, p ¼ 0.05) and a higher
prevalence of intimal microchannels (46% vs. 11%,
p ¼ 0.02) on OCT (82). Intimal thickness as measured
by OCT increases with time since transplantation (83),
and OCT enables the identiﬁcation of early features of
cardiac allograft vasculopathy before development of
angiographic features (84). Presence of vulnerable
plaque features such as TCFA and macrophage inﬁl-
tration increases with time from transplantation, and
complex lesions such as intimal laceration and plaque
rupture are also more prevalent (85).
LIMITATIONS OF OCT
A major limitation of OCT is its requirement for a
blood-free ﬁeld, necessitating ﬂushing with either
saline or contrast during image acquisition. Any
contamination with blood during pullback results in
loss of image data due to backscattering. Differenti-
ation of calcium and lipid pool is more challenging
than with IVUS, as both give low-attenuation signals
(86). Moreover, the limited ranging depth of OCT
(5 to 6 mm) means that imaging of the left main stem
and vein grafts is limited (13), and calculation of
plaque volume may be inaccurate (7). Poor penetra-
tion of light through lipid-rich tissue also limits its
use in quantifying certain plaque components. Im-
aging artifacts plague up to a third of OCT images andthrombus obscures the morphology of the under-
lying lesion. Plaque analysis of OCT images for
features of vulnerability is currently performed on
a frame-by-frame basis and is therefore time
consuming and not feasible in real time in the cath-
eter laboratory, although automated processes for
luminal border detection and plaque composition
appear promising (87).
CONCLUSIONS
The detailed spatial resolution provided by OCT has
allowed detailed in vivo correlation of those histo-
pathological features thought to underlie plaque
vulnerability. This has led to greater insight into the
prevalence of vulnerable plaques in patients pre-
senting with ACS, particularly in nonculprit vessels.
Although there is lack of clinical data to guide the
management of vulnerable lesions, a greater under-
standing of their natural history and temporal res-
ponse to pharmacological or invasive interventions
may help to deepen the understanding of ACS
pathophysiology.
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